Page last updated: 2024-09-05

sb 203580 and Encephalitis

sb 203580 has been researched along with Encephalitis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Castaño, A; García-Cuervo, L; Jiménez, S; Pintado, C; Revilla, E; Ruano, D; Vitorica, J; Vizuete, ML1
Desobry, K; Gay, D; Grammas, P; Luo, J; Martinez, J; Riley, J; Sanchez, A; Tripathy, D; Yin, X1

Other Studies

2 other study(ies) available for sb 203580 and Encephalitis

ArticleYear
Regional difference in inflammatory response to LPS-injection in the brain: role of microglia cell density.
    Journal of neuroimmunology, 2011, Sep-15, Volume: 238, Issue:1-2

    Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents; Cell Count; Cell Line, Transformed; Cytokines; Disease Models, Animal; Encephalitis; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Imidazoles; Interleukin-10; Isothiuronium; Lipopolysaccharides; Male; Mice; Microglia; Nitric Oxide Synthase Type II; Pyridines; Rats; RNA, Messenger; Tumor Necrosis Factor-alpha

2011
p38 MAPK: a mediator of hypoxia-induced cerebrovascular inflammation.
    Journal of Alzheimer's disease : JAD, 2012, Volume: 32, Issue:3

    Topics: Alzheimer Disease; Animals; Cell Hypoxia; Cells, Cultured; Cerebrovascular Disorders; Encephalitis; Humans; Imidazoles; Mice; Mice, Transgenic; Microvessels; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats

2012